Form 4: RenovoRx Director Receives Stock Grant
Insider Transaction (Form 4)
K. Angela Macfarlane, a Director of RenovoRx, Inc., received 55,924 shares of common stock on October 1, 2026.
Summary
- Grant/award: acquired 55,924 Stock Options (right to buy) on October 1, 2026; holds 55,924 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
K. Angela Macfarlane — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Grant/award | Stock Options (right to buy) | 55,924 | — | — | 55,924 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Grant/award (55,924 shares) |
Keywords
insider transaction, Form 4, RNXT, RenovoRx, Inc., neutral, K. Angela Macfarlane
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.